Solventum
Prix: 78.87Entreprise et modèle économique
Solventum operates in the healthcare sector, focusing on the development and commercialization of innovative medical solutions. Its core products include advanced therapeutic devices and diagnostic tools aimed at improving patient outcomes. The company generates revenue primarily through product sales and partnerships with healthcare providers and institutions. Solventum's business segments encompass research and development, manufacturing, and distribution of healthcare technologies.
Profil d’investissement
The investment profile of Solventum is more aligned with growth investors, given its focus on innovation and potential for revenue expansion. The company shows stable earnings growth and a moderate risk profile, appealing to those seeking capital appreciation. Its performance metrics suggest a favorable outlook for long-term investment strategies.
Métriques fondamentales (expérimental)
- BPA (TTM) — bénéfice par action des 12 derniers mois, $
- 8.21 OK
- Chiffre d’affaires QoQ — croissance trimestrielle du chiffre d’affaires
- 0.5% ≈
- Surprise BPA
- 9.6% meilleur que prévu
- Volatilité 20 j
- 2.1% stable
Impact de la prévision
épuiséSuivre dans le portefeuille
Graphique des prix
| Date | Avant | Après | Raison |
|---|---|---|---|
| 2026-06-10 00:49 | Conserver | Acheter | Strong momentum and positive EPS surprise indicate growth potential. |
| 2026-06-09 02:51 | Acheter | Conserver | Mixed performance and uncertain market conditions. |
| 2026-06-05 02:48 | Conserver | Acheter | Strong momentum and solid EPS growth support bullish outlook. |
| Date | Analyste | Action | Objectif | Prix alors |
|---|---|---|---|---|
| 2026-06-01 11:15 | Jefferies | Objectif relevé | — → 43 | 74.95 |
| 2026-05-15 11:13 | Wedbush | Mettre à jour | — → 94 | 74.42 |
| 2026-05-06 13:34 | UBS | Objectif abaissé | 82 → 78 | 71.355 |
Rien pour le moment